AdaptHealth to sell Diabetes Health business to Cardinal Health for $235M cash

AdaptHealth Corp.

Purchase price $235M cash, subject to customary net working capital adjustment.
Escrow: $8.0M for purchase price adjustment; $18.8M for indemnification obligations.
Transaction subject to HSR review and other customary closing conditions; expected within 12 months.
AdaptHealth to focus on core sleep, respiratory, and HME; plans to use proceeds for debt reduction and reinvestment.
Company will provide financial guidance update on Q2 2026 earnings call scheduled for August 4, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.